[Enhanced resistance of the brain to hypoxia by the joint use of lithium oxybutyrate and indomethacin].
D000208:Acute Disease; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000503:physiopathology; D004353:Drug Evaluation, Preclinical; D004562:Electrocardiography; D004569:Electroencephalography; D006885:Hydroxybutyrates / Q000627:therapeutic use*; D002534:Hypoxia, Brain / Q000503:physiopathology / Q000517:prevention & control*; D007213:Indomethacin / Q000627:therapeutic use*; D008094:Lithium / Q000627:therapeutic use*; D008297:Male; D009942:Organometallic Compounds; D051381:Rats; D012121:Respiration, Artificial; D013997:Time Factors
D006885:Hydroxybutyrates; D009942:Organometallic Compounds; C022826:lithium hydroxybutyrate; D008094:Lithium; D007213:Indomethacin
Povyshenie rezistentnosti mozga k gipoksii s pomoshch'iu sochetannogo primeneniia oksibutirata litiia i indometametsina.